| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
1998-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2005-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f1dbb99e3e61c2f419b466ccc2ec247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c21842a2250cdb46dbb7544ae2fea7d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_888394de47a0c268c1da9b3f1a250671
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8911a95d3ede8632d36031b002ad0423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd2d074faf2941feaad7c82bdb7ac46c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbdefb64aad19af7de09c2c08967cd17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7ff3f0f16656d6c545bf7fd58e846fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7df4002722698589c5e66aec4478b68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bc0a473eff4eb60ba849b7c0d2b551c |
| publicationDate |
2005-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6919086-B1 |
| titleOfInvention |
Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same |
| abstract |
The invention relates to modified recombinant allergen mutants which can be obtained from recombinant allergens which are derived from allergens which can be obtained by extraction from natural raw materials such as pollen of the species Phleum pratense. While these modified recombinant allergens stimulate lymphocytes from patients who are allergic to pollent to proliferate and synthesize cytokines, they exhibit a markedly diminished ability to bind to the IgE antibodies which are present in the serum of the T lymphocyte donors and to grass pollen allergen-specific IgEs and can therefore be used for a specific, made-to-release allergy therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9975932-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8329196-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008187558-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008193535-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004166123-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9415015-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10471008-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9408805-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10080719-B2 |
| priorityDate |
1997-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |